Specialist in data discovery, knowledge graphs, search and data interaction, Siren, has completed a seed round worth €3 million, which it will use to bring its semantic data investigation platform to new sectors, including life sciences.

Euros

“Our unique semantic approach enables fast responses to complex data investigation challenges. Our initial focus has been on working with national security services and police, where the mission-critical investigation of data is often done under intense time pressure,” explained founder and chief product officer Giovanni Tummarello. “These capabilities have not previously been readily accessible in other sectors but we are now working with some of the largest financial and life sciences organisations to enable cross-dataset real time investigation.”

“Data is becoming a recognised asset in every firm in every industry but there is widespread frustration when it comes to solving problems with data. Siren’s data investigation capability meets that need in a way I have never seen in 20 years in the industry,” stated John Randles, CEO Siren.

The investment round was led by the Atlantic Bridge University Fund, which invests in companies built from world-class research.

“On behalf of Atlantic Bridge I am delighted to join the Siren Board and be an active investor and partner to the team who we believe have developed cutting edge data intelligence technologies,” added Gerry Maguire, general partner, Atlantic Bridge. “The strength of the research from National University of Ireland, Galway which is at the core of Siren’s technology platform is an impressive example of how companies can leverage the outputs of Irish research to create unique solutions that solve complex problems for customers globally.”

Join the EPM Community for FREE today!

EPM Magazine is the essential information source for professionals involved in the formulation, development, manufacturing and supply of drugs and medicines in the pharmaceutical and biopharmaceutical industry.